> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hahn’s FDA Nomination Heads to Full Senate
- URL: https://www.fdaweb.com/hahns-fda-nomination-heads-to-full-senate/
- Published: 2019-12-03T12:00:00.000Z
- Updated: 2026-09-14T15:55:07.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145628

Two weeks after sailing though his confirmation hearing ([see earlier story](https://www.fdaweb.com/hahn-meets-praise-resistance-during-fda-confirmation/)), the Senate Health, Education, Labor & Pensions Committee 12/3 voted 18 to 5 to advance **Stephen Hahn**’s nomination to serve as FDA commissioner to the full Senate for consideration. “Dr. Hahn has extensive medical and research experience and is a proven leader in large health systems—all around, he is exactly the type of nominee we want to lead an agency as important as the FDA,” Committee chair **Lamar Alexander** (R-TN) said before the vote.

“The Committee has received thirteen letters of support for Dr. Hahn representing nearly 80 organizations on behalf of doctors, patients, researchers, and from his colleagues,” Alexander continued. “In addition, five previous FDA commissioners, who served under Presidents Trump, Obama and Bush wrote: ‘We believe Dr. Hahn has the experience and commitment to public health and public service needed to provide this leadership… we hope that Dr. Hahn will be able to bring his clinical expertise, leadership experience, and commitment to public service and science to the FDA as soon as possible.’”